ACE and chronic kidney disease: First-line treatment for CKD includes renin–angiotensin system (RAS) inhibition, in the form of angiotensin converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs), and sodium-glucose co-transporter 2 inhibitors (SGLT2i) [6].